Table 1.
Patient characteristics at baseline.
| Characteristics no./no. (%) | All patients | Women | Men | p-Value (men vs women)a |
|---|---|---|---|---|
| Exitus | 2020/12,126 (16.7) | 800/5667 (14.1) | 1220/6459 (18.9) | <0.001 |
| Age, years | ||||
| 18–39 | 904/12,126 (7.5) | 500/5667 (8.8) | 404/6459 (6.3) | <0.001 |
| 40–49 | 1262/12,126 (10.4) | 624/5667 (11.0) | 638/6459 (9.9) | |
| 50–59 | 2028/12,126 (16.7) | 941/5667 (16.6) | 1087/6459 (16.8) | |
| 60–69 | 2170/12,126 (17.9) | 867/5667 (15.3) | 1303/6459 (20.2) | |
| 70–79 | 2382/12,126 (19.6) | 1061/5667 (18.7) | 1321/6459 (20.5) | |
| ≥80 | 3380/12,126 (27.9) | 1674/5667 (29.5) | 1706/6459 (26.4) | |
| Preexisting comorbidities | ||||
| HBP | 6276/12,114 (51.8) | 2857/5659 (50.5) | 3419/6455 (53) | 0.006 |
| Obesity | 2100/11,186 (18.8) | 967/5280 (18.3) | 1133/5906 (19.2) | 0.240 |
| Cardiac pathology | 3006/12,109 (24.8) | 1236/5657 (21.8) | 1770/6452 (27.4) | <0.001 |
| Respiratory pathology | 2735/12,099 (22.6) | 1085/5652 (19.2) | 1650/6447 (25.6) | <0.001 |
| Symptoms | ||||
| Anosmia | 653/12,119 (5.4) | 367/5663 (6.5) | 286/6456 (4.4) | <0.001 |
| Diarrhea | 2048/12,121 (16.9) | 1066/5664 (18.8) | 982/6457 (15.2) | <0.001 |
| Vomiting | 899/12,121 (7.4) | 543/5664 (9.6) | 356/6457 (5.5) | <0.001 |
| Fever | 7543/12,120 (62.2) | 3240/5663 (57.2) | 4303/6457 (66.6) | <0.001 |
| Dyspnea | 6870/12,121 (56.7) | 3110/5664 (54.9) | 3760/6457 (58.2) | <0.001 |
| Cough | 6829/12,120 (56.3) | 3109/5663 (54.9) | 3720/6457 (57.6) | 0.003 |
| Clinical features | ||||
| Lung infiltrations | 8921/11,873 (75.1) | 3828/5507 (69.5) | 5093/6366 (80) | <0.001 |
| Lymphopenia | 6629/11,565 (57.3) | 2781/5324 (52.2) | 3848/6241 (61.7) | <0.001 |
| D-dimer ≥ 1000 ng/mL | 4436/10,191 (43.5) | 1928/4610 (41.8) | 2508/5581 (44.9) | 0.002 |
| Treatments | ||||
| Invasive ventilation | 530/12,126 (4.4) | 174/5667 (3.1) | 356/6459 (5.5) | <0.001 |
| Non-invasive ventilation | 764/12,124 (6.3) | 291/5667 (5.1) | 437/6457 (7.3) | <0.001 |
| Antiretroviral treatment | 3337/12,124 (27.5) | 1262/5666 (22.3) | 2075/6458 (32.1) | <0.001 |
| Chloroquine | 7910/12,124 (65.2) | 3410/5666 (60.2) | 4500/6458 (69.7) | <0.001 |
| Interferon β-1b | 292/12,123 (2.4) | 89/5666 (1.6) | 203/6457 (3.1) | <0.001 |
| Azithromycin | 7741/12,120 (63.9) | 3431/5665 (60.6) | 4310/6455 (66.8) | <0.001 |
| Corticosteroids | 4785/12,119 (39.5) | 1862/5664 (32.9) | 2923/6455 (45.3) | <0.001 |
| Tocilizumab | 370/12,118 (3.1) | 120/5664 (2.1) | 250/6454 (3.9) | <0.001 |
HBP: high blood pressure.
a
Pearson's Chi-square test. Significant differences were considered when p < 0.05.
Patient Characteristics at Baseline. Data are collected as counts and percentages n (%).